Maria Procaccianti

Hepatotoxicity in patients prescribed efavirenz or nevirapine.

Sandra Brück, S. Witte, Jürgen Brust et al. · PubMed · 2008 · 60 citations

Pharmacy, Pharmacology, Pharmacotherapy +10

Deferasirox treatment of iron‐overloaded chelation‐naïve and prechelated patients with myelodysplastic syndromes in medical practice: results from the observational studies eXtend and eXjange

Norbert Gattermann, Andrea Jarisch, Rudolf Schlag et al. · European Journal Of Haematology · 2011 · 38 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

The impact of allogeneic stem cell transplantation on the natural course of poor-risk chronic lymphocytic leukemia as defined by the EBMT consensus criteria: a retrospective donor versus no donor comparison

Isabelle Herth, Sascha Dietrich, Axel Benner et al. · Annals of Oncology · 2013 · 38 citations · Full text

Medicine, Immunology, Oncology +17

Elotuzumab, lenalidomide, bortezomib, dexamethasone, and autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GMMG-HD6): results from a randomised, phase 3 trial

Hartmut Goldschmidt, Kaya Miah, Uta Bertsch et al. · The Lancet Haematology · 2024 · 20 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

Comparison of efavirenz and nevirapine in HIV-infected patients (NEEF Cohort)

Martin Hartmann, Steffen Witte, Jürgen Brust et al. · International Journal of STD & AIDS · 2005 · 14 citations

Pharmacy, Pharmacotherapy, Clinical Pharmacology +16